LETTER
More on the GUSTO Trial
Paul M. Ridker;
Christopher O'Donnell;
Victor J. Marder; and
Charles H. Hennekens
15 November 1994 | Volume 121 Issue 10 | Pages 818-820
TO THE EDITOR:
We were surprised to read the letter by Lee and colleagues [1]. We had been requested by the Editors of Annals to respond to their commentary [2] and were provided with only two versions—an original dated 30 October 1993 and a revised draft dated 24 January 1994. Both drafts, provided by the GUSTO investigators to Annals, stated that the rates of coronary artery bypass surgery were 9.5% for accelerated tissue plasminogen activator (tPA) and 8.5% for streptokinase.
1. Lee KL, Califf RM, Topol EJ. The last word on GUSTO, for now (Letter). Ann Intern Med. 1994; 120:970.
2. Lee KL, Califf RM, Simes J, Van de Werf F, Topol EJ, for the GUSTO Investigators. Holding GUSTO up to the light. Ann Intern Med. 1994; 120:876-81.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Top
References
Article
